Zoloft Linked to Persistent Pulmonary Hypertension of the Newborn (PPHN) and Other Serious Birth Defects, Notes Hissey Kientz, LLP
Austin, TX (PRWEB) September 12, 2013 -- The law firm of Hissey Kientz, LLP is announcing the launch of a new division of their legal information resource website, Zoloft Birth Defects Lawyers (http://www.zoloftbirthdefectslawyers.com), dedicated to information regarding Persistent Pulmonary Hypertension of the Newborn (PPHN) and other heart defects that could be caused by the use of Zoloft during pregnancy. The new section will also include information on heart defects such as ventricular outflow defects, coarctation of the aorta, tetralogy of fallot, patent ductus arteriosus, bicuspid aortic valve, cleft mitral valve and cardiomyopathy.
A New England Journal of Medicine (NEJM) study published in February 2006 found that women who take SSRIs such as Zoloft after the 20th week of pregnancy are six times more likely to give birth to a child with PPHN than mothers who do not take SSRI antidepressants.*
An article published on January 2, 2012 by the British Medical Journal (BMJ) also found that women who took Zoloft before the eighth week of pregnancy faced an increased risk of giving birth to a child with PPHN compared to women who took other antidepressants.**
The Food and Drug Administration (FDA) issued a warning in 2006 regarding the potential side effects of taking SSRIs while pregnant. The FDA advised women to speak with their doctors about the relative risks of birth defects from Zoloft in order to determine whether they should discontinue the use of the drug during their pregnancy.***
If you or a loved one took Zoloft during pregnancy and gave birth to a child with heart defects or other congenital birth defects, you may be eligible to file a lawsuit. For a free legal consultation, contact the lawyers at Hissey Kientz, LLP by calling toll-free at 1-866-275-4454, or by email at info(at)hkllp(dot)com.
*http://www.nejm.org/doi/full/10.1056/NEJMoa052744
**http://www.bmj.com/highwire/filestream/557867/field_highwire_article_pdf/0.pdf
***http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm126522.htm
About Hissey Kientz, LLP
Hissey Kientz, LLP represents individuals experiencing complications from Zoloft use during pregnancy, as well as victims of mesothelioma and other asbestos-related diseases, Mirena IUDs, Stryker and BioMet hip replacements, transvaginal mesh implants, GranuFlo dialysis concentrate and other defective drugs and medical devices.
Allison Sass, Hissey Kientz LLP, http://www.hkllp.com, 1-866-275-4454, [email protected]
Share this article